Increase in nalidixic acid resistance among non-typhi Salmonella enterica isolates in the United States from 1996 to 2003

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 1, 2007, Pages 195-197

  Stevenson, Jennifer E ^a,c   Gay, Kathryn ^a   Barrett, Timothy J ^a   Medalla, Felicita ^a   Chiller, Tom M ^a   Angulo, Frederick J ^a,b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; GENE; GYRA GENE; GYRB GENE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NALIDIXIC ACID RESISTANT SALMONELLA; NONHUMAN; PARC GENE; PARE GENE; POINT MUTATION; PREVALENCE; PRIORITY JOURNAL; QNR GENE; SALMONELLA; SALMONELLA ENTERICA; SALMONELLOSIS;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; POINT MUTATION; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SENTINEL SURVEILLANCE; UNITED STATES;

EID: 33845990601     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00222-06     Document Type: Article

References (20)

1. Angulo, F., V. Nargund, and T. Chiller. 2004. Evidence of association between use of antimicrobial agents in food animals and antimicrobial resistance among bacteria isolated from humans and the human health consequences of such resistance. J. Vet. Med. B 51:374-379.
2. Brenner, F. M. 1998. Identification and serotyping of Salmonella. National Salmonella Reference Laboratory, Centers for Disease Control and Prevention, Atlanta, GA.
3. Centers for Disease Control and Prevention. 2004. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): 2002 annual report. U.S. Department of Health and Human Services, CDC, Atlanta, GA.
4. Centers for Disease Control and Prevention. 2004. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food-selected sites, United States, 2003. Morb. Mortal. Wkly. Rep. 53:338-343.
5. Crump, J. A., T. J. Barrett, J. T. Nelson, and F. J. Angulo. 2003. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin. Infect. Dis. 37:75-81.
6. FDA. 2001. FDA withdraws approval of two poultry drugs. FDA Consumer 35:5.
7. Gay, K., A. Robicsek, J. Strahilevitz, C. H. Park, G. Jacoby, T. J. Barrett, F. Medalla, T. M. Chiller, and D. C. Hooper. 2006. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin. Infect. Dis. 43:297-304.
8. Gupta, A., J. M. Nelson, T. J. Barrett, R. V. Tauxe, S. P. Rossiter, C. R. Friedman, K. W. Joyce, K. E. Smith, T. F. Jones, M. A. Hawkins, B. Shiferaw, J. L. Beebe, D. J. Vugia, T. Rabatsky-Ehr, J. A. Benson, T. P. Root, and F. J. Angulo. 2004. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg. Infect. Dis. 10:1102-1109.
9. Hakanen, A., P. Kotilainen, P. Huovinen, H. Helenius, and A. Siitonen. 2001. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg. Infect. Dis. 7:996-1003.
10. Kimura, A. C., V. Reddy, R. Marcus, P. R. Cieslak, J. C. Mohle-Boetani, H. D. Kassenborg, S. D. Segler, F. P. Hardnett, T. J. Barrett, and D. L. Swerdlow. 2004. Chicken consumption is a newly identified risk factor for sporadic Salmonella enterica serotype Enteritidis infections in the United States: a case-control study in FoodNet sites. Clin. Infect. Dis. Suppl. 38: 244-252.
11. Mølbak, K., D. L. Baggesen, F. M. Aarestrup, J. M. Ebbesen, J. Engberg, K. Frydendahl, P. Gerner-Smidt, A. M. Petersen, and H. C. Wegener. 1999. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N. Engl. J. Med. 341:1420-1425.
12. NCCLS. 2004. Performance standards for antimicrobial susceptibility testing: 14th informational supplement. NCCLS document M100 S14 (ISBN 1 56238 516 X). NCCLS, Wayne, PA.
13. Nelson, J. M., K. E. Smith, D. J. Vugia, T. Rabatsky-Ehr, S. D. Segler, H. D. Kassenborg, S. M. Zansky, K. Joyce, N. Marano, R. M. Hoekstra, and F. J. Angulo. 2004. Prolonged diarrhea due to ciprofloxacin-resistant Campylobacter. J. Infect. Dis. 190:1150-1157.
14. Nelson, J. M., D. Vugia, A. Daniels, S. Hurd, M. Park, D. Blythe, S. Wedel, B. J. Anderson, A. Ingram, K. Joyce, and F. J. Angulo. 2004. Increasing incidence of nalidixic acid-resistant Salmonella: FoodNet and NARMS 1996-2002, abstr. 551. Abstr. 42nd Infect. Dis. Soc. Am. Infectious Diseases Society of America, Boston, MA.
15. Olsen, S., E. DeBess, T. McGivern, N. Marano, T. Eby, S. Mauvais, V. Balan, G. Zirnstein, P. Cieslak, and F. J. Angulo. 2001. A nosocomial outbreak of fluoroquinolone-resistant Salmonella infections in Oregon. N. Engl. J. Med. 344:1572-1579.
16. Oteo, J., B. Aracil, J. L. Alos, and J. L. Gomez-Garces. 2000. High rate of resistance to nalidixic acid in Salmonella enterica: its role as a marker of resistance to fluoroquinolones. Clin. Microbiol. Infect. 6:273-276.
17. Piddock, L. J. 2002. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol. Rev. 26:3-16.
18. U.S. Food and Drug Administration. 2005. Enrofloxacin for poultry; final decision on withdrawal of new animal drug application following formal evidentiary public hearing; availability, p. 44105 [FR Doc. 05-15224]. Docket no. 2000N-1571, OC 2005193. U.S. Food and Drug Administration, Rockville, MD.
19. Varma, J. K., K. Mølbak, T. J. Barrett, J. L. Beebe, T. F. Jones, T. Rabatsky-Ehr, K. E. Smith, D. J. Vugia, H. H. Chang, and F. J. Angulo. 2005. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J. Infect. Dis. 191:554-561.
20. Voetsch, A. C., T. J. Van Gilder, F. J. Angulo, M. M. Parley, S. Shallow, R. Marcus, P. R. Cieslak, V. C. Deneen, and R. V. Tauxe. 2004. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin. Infect. Dis. Suppl. 38:127-134.